IMMUNE DESIGN CORP COMMON STOCK (IMDZ) earnings
Quarterly and annual IMDZ reports and results, each read against the price at its own news timestamp. Back to the IMDZ overview →
No IMDZ earnings events in the measured window.
Nothing matched in the current window — the IMDZ overview has every event we measure for this name.
Get an email when IMDZ moves on news →Keep exploring
More IMDZ: analyst actions → · SEC filings → · IMDZ overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Charles River Laboratories International, Inc. (CRL) | 434 | -0.10% | 45% |
| Nymox Pharmaceutical Corporation (NYMX) | 433 | 0.00% | 48% |
| CRH MEDICAL CORP (CRHM) | 431 | 0.00% | 39% |
| Globus Medical, Inc. Class A (GMED) | 431 | +0.02% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.